Gets a Neutral rating from RBC ZD 12:28am French and Benelux stocks-Factors to watch RE Oct. 15 Sanofi Signs Letter of Intent With Canadian Drug Alliance for Dupixent in Four Additional Indications MT ...

【財華社訊】北京時間2026年10月16日晚間，美股周五早盤，知名美股跌幅榜前十名分別為Recursion Pharmaceuticals, Inc. Class A(RXRX.US)跌幅7.09%、RYTHM, Inc.(RYM.US)跌幅7.01%、Cloudflare Inc Class A(NET.US)跌幅5.44%、Datadog, Inc. Class A(DDOG.US)跌幅4.7 ...

Phase-1-Studien sind für 2027 geplant. Die Sanofi-Aktie kostet am 16.10.2026 71,56 Euro, 1,16 Prozent unter dem Xetra-Schluss ...

【財華社訊】北京時間2026年10月17日淩晨，美股周五收盤，知名美股跌幅榜前十名分別為Recursion Pharmaceuticals, Inc. Class A(RXRX.US)跌幅16.71%、美國先鋒(AVD.US)跌幅15.20%、Nebius Group N.V. Class A(NBIS.US)跌幅12.18%、Rackspace Technology, Inc.(RXT.US)跌 ...

Report Tracks Roche Diagnostics, Thermo Fisher, Illumina, Agilent and Guardant Health Among 132 Companies, With Forecasts by Assay Type, Technology, Customer and CountryDublin, Oct. 16, 2026 (GLOBE ...

10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与项飙现场对话！ 名额有限，手慢无。让我们共赴可持续之约！【点击报名】 ...

In his latest research note, analyst Trung Huynh confirms his recommendation. The broker RBC is keeping its Neutral rating. The target price is lowered from EUR 80 to EUR 75.

22nd Century Group Inc. XXII shares jumped 64.22% to $1.03 in after-hours trading on Thursday, after the company reported a ...

Les actions de Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) sont en hausse vendredi. Les actions de la société de biotechnologie en phase clinique basée ...

Recursion Pharmaceuticals Inc. RXRX shares are trending on Friday. Shares of the Utah-based clinical-stage biotechnology ...

Sanofi übernimmt Finanzierung und Leitung des Kandidaten; der Start einer Phase-1-Studie ist für 2027 vorgesehen.

Le titre de 22nd Century Group (XXII) s’envole de plus de 64 % après la clôture grâce à la croissance des ventes | % ...